Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030GlobeNewsWire • 09/08/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROWGlobeNewsWire • 08/17/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROWPRNewsWire • 08/16/25
Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a BetZacks Investment Research • 08/15/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROWGlobeNewsWire • 08/09/25
Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 08/04/25
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025GlobeNewsWire • 07/29/25
Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United StatesBusiness Wire • 07/17/25
Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United StatesBusiness Wire • 07/17/25
HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law FirmPRNewsWire • 07/15/25